KBC Group
SPPI

KBC Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

KBC Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-247,582
Closed -$319K – 1632
2022
Q1 		$319K Buy
+247,582
New +$228K ﹤0.01% 926
2020
Q3 		– Sell
-119,210
Closed -$453K – 1297
2020
Q2 		$402K Buy
+119,210
New +$347K ﹤0.01% 1067
2020
Q1 		– Sell
-67,159
Closed -$244K – 1482
2019
Q4 		$244K Hold
67,159
– – ﹤0.01% 1259
2019
Q3 		$557K Buy
+67,159
New +$543K ﹤0.01% 1046
2017
Q2 		– Sell
-85,230
Closed -$554K – 1344
2017
Q1 		$554K Hold
85,230
– – 0.01% 1021
2016
Q4 		$378K Sell
85,230
-1,501
-2% -$6.3K ﹤0.01% 1091
2016
Q3 		$405K Hold
86,731
– – ﹤0.01% 1016
2016
Q2 		$570K Hold
86,731
– – 0.01% 841
2016
Q1 		$552K Buy
+86,731
New +$445K 0.01% 812

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

KBC Group's SPPI Position: Q2 2022 in Review

KBC Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 247,582 shares — an estimated $319K sold.

KBC Group first reported a position in SPPI in Q1 2016 and held it in 9 quarters. The position peaked at $570K in Q2 2016. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • KBC Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • KBC Group sold 247,582 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $319K.
  • KBC Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 9 quarters.
  • KBC Group's Spectrum Pharmaceuticals Inc position peaked at $570K in Q2 2016.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.